Print

Cadence Pharmaceuticals, Inc. CEO Ted Schroeder to Present at the Leerink Swann and Company 2012 Global Healthcare Conference on February 15, 2012  
2/10/2012 9:01:55 AM

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, February 15, 2012 at 8:00am Eastern Time (5:00am Pacific Time) during the Leerink Swann 2012 Global Healthcare Conference at the Waldorf Astoria Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page. A replay of the webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. In January 2011, Cadence commercially launched OFIRMEV (acetaminophen) injection, an intravenous formulation of acetaminophen, in the U.S. For more information about Cadence, please visit www.cadencepharm.com.

Contacts:

William R. LaRue

SVP, CFO

Cadence Pharmaceuticals, Inc.

858-436-1400

SOURCE Cadence Pharmaceuticals


//-->